These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9377102

  • 1. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with noncyclic gastrin receptor antagonistic moieties.
    Kawanishi Y, Ishihara S, Kiyama R, Hagishita S, Tsushima T, Ishikawa M, Ishihara Y.
    Bioorg Med Chem; 1997 Jul; 5(7):1425-31. PubMed ID: 9377102
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with decreased hydrophobicity.
    Kawanishi Y, Ishihara S, Tsushima T, Hagishita S, Ishikawa M, Ishihara Y.
    Bioorg Med Chem; 1997 Jul; 5(7):1401-9. PubMed ID: 9377100
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with modified benzodiazepine skeletons.
    Kawanishi Y, Ishihara S, Tsushima T, Seno K, Hagishita S, Ishikawa M, Ishihara Y.
    Bioorg Med Chem; 1997 Jul; 5(7):1411-23. PubMed ID: 9377101
    [Abstract] [Full Text] [Related]

  • 4. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
    Yuki H, Nishida A, Miyake A, Ito H, Akuzawa S, Takinami Y, Takemoto Y, Miyata K.
    Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of a new reversely linked type of dual histamine H2 and gastrin receptor antagonist.
    Kawanishi Y, Ishihara S, Takahashi K, Tsushima T, Hagishita S, Ishikawa M, Ishihara Y.
    Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):116-24. PubMed ID: 9023973
    [Abstract] [Full Text] [Related]

  • 6. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F, Revel L, Letari O, Mennuni L, Impicciatore M.
    Eur J Pharmacol; 1999 Mar 12; 369(1):81-90. PubMed ID: 10204685
    [Abstract] [Full Text] [Related]

  • 7. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, Ohta M, Satoh M, Semple G, Miyata K.
    Aliment Pharmacol Ther; 1997 Feb 12; 11(1):113-20. PubMed ID: 9042983
    [Abstract] [Full Text] [Related]

  • 8. Potent and subtype-selective CCK-B/gastrin receptor antagonists: 2,4-dioxo-1,5-benzodiazepines with a plane of symmetry.
    Hagishita S, Seno K, Kamata S, Haga N, Ishihara Y, Ishikawa M, Shimamura M.
    Bioorg Med Chem; 1997 Jul 12; 5(7):1433-46. PubMed ID: 9377103
    [Abstract] [Full Text] [Related]

  • 9. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Håkanson R, Ding XQ, Norlén P, Lindström E.
    Regul Pept; 1999 Mar 17; 80(1-2):1-12. PubMed ID: 10235629
    [Abstract] [Full Text] [Related]

  • 10. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
    Ding XQ, Håkanson R.
    Pharmacol Toxicol; 1996 Dec 17; 79(6):324-30. PubMed ID: 9000260
    [Abstract] [Full Text] [Related]

  • 11. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H, Ito H, Higaki M, Higaki M, Matsumoto Y, Kamimura T, Katsura Y, Tomishi T, Inoue Y, Takasugi H, Tomoi M, Krakowka S, Yoshida K.
    Eur J Pharmacol; 1999 Aug 13; 378(3):299-310. PubMed ID: 10493106
    [Abstract] [Full Text] [Related]

  • 12. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
    Shibata M, Yamaura T, Inaba N, Onodera S, Chida Y, Ohnishi H.
    Eur J Pharmacol; 1993 Apr 28; 235(2-3):245-53. PubMed ID: 8099553
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.
    Roberts SP, Harper EA, Watt GF, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1996 Aug 28; 118(7):1779-89. PubMed ID: 8842444
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.
    Hills DM, Gerskowitch VP, Roberts SP, Welsh NJ, Shankley NP, Black JW.
    Br J Pharmacol; 1996 Dec 28; 119(7):1401-10. PubMed ID: 8968549
    [Abstract] [Full Text] [Related]

  • 15. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
    Satoh M, Okamoto Y, Koshio H, Ohta M, Nishida A, Akuzawa S, Miyata K, Mase T, Semple G.
    Chem Pharm Bull (Tokyo); 1996 Jul 28; 44(7):1412-4. PubMed ID: 8706146
    [Abstract] [Full Text] [Related]

  • 16. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K.
    J Med Chem; 1997 Jan 31; 40(3):331-41. PubMed ID: 9022799
    [Abstract] [Full Text] [Related]

  • 17. Antisecretory and gastroprotective activities of compounds endowed with H2 antagonistic and nitric oxide (NO) donor properties.
    Coruzzi G, Adami M, Morini G, Pozzoli C, Cena C, Bertinaria M, Gasco A.
    J Physiol Paris; 2000 Jan 31; 94(1):5-10. PubMed ID: 10761682
    [Abstract] [Full Text] [Related]

  • 18. Are C-terminal octapeptide of cholecystokinin and [Leu11]gastrin-(5-17) different in stimulating acid secretion in isolated rabbit gastric glands?
    Oiry C, Galleyrand JC, Lima-Leite AC, Fulcrand P, Martinez J.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):511-9. PubMed ID: 8750713
    [Abstract] [Full Text] [Related]

  • 19. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
    Schmassmann A, Garner A, Flogerzi B, Hasan MY, Sanner M, Varga L, Halter F.
    Gut; 1994 Feb 29; 35(2):270-4. PubMed ID: 8307482
    [Abstract] [Full Text] [Related]

  • 20. Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
    Bock MG, DiPardo RM, Evans BE, Rittle KE, Veber DF, Freidinger RM, Chang RS, Lotti VJ.
    J Med Chem; 1988 Jan 29; 31(1):176-81. PubMed ID: 3336017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.